KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Prepaid Assets (2019 - 2025)

Royalty Pharma (RPRX) has disclosed Prepaid Assets for 7 consecutive years, with $6.9 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 64.63% to $6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Dec 2025, up 64.63% year-over-year, with the annual reading at $6.9 million for FY2025, 64.63% up from the prior year.
  • Prepaid Assets hit $6.9 million in Q4 2025 for Royalty Pharma, up from $5.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $90.5 million in Q4 2022 to a low of $2.3 million in Q2 2024.
  • Historically, Prepaid Assets has averaged $18.2 million across 5 years, with a median of $6.6 million in 2021.
  • Biggest five-year swings in Prepaid Assets: surged 1265.1% in 2022 and later tumbled 92.51% in 2023.
  • Year by year, Prepaid Assets stood at $6.6 million in 2021, then soared by 1265.1% to $90.5 million in 2022, then crashed by 80.07% to $18.0 million in 2023, then plummeted by 76.79% to $4.2 million in 2024, then soared by 64.63% to $6.9 million in 2025.
  • Business Quant data shows Prepaid Assets for RPRX at $6.9 million in Q4 2025, $5.5 million in Q3 2025, and $4.5 million in Q2 2025.